Correction to Medtronic CoreValve FDA Approval Story
January 17 2014 - 5:09PM
Dow Jones News
"FDA Approves Medtronic's CoreValve Heart Device -- 2nd Update"
at 4:10 pm ET misstated that transcatheter heart valve procedures
cost upwards of $30,000 in the seventh paragraph. The heart valve
used in the procedure costs upwards of $30,000.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2024 to May 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From May 2023 to May 2024